Acuta Capital Partners, LLC New Holdings in Q2 2024

Acuta Capital Partners, LLC

  • $92.9 Million
  • Q2 2024
Stock Shares change Price Range Shares Held Trade History
ARGX
Argenx Se

Healthcare
4K
New
$356.01 - $451.55 $1.42M - $1.81M
4K $1.72M
TRVI
Trevi Therapeutics, Inc.

Healthcare
260K
New
$2.44 - $3.36 $634K - $874K
260K $774K
CELC
Celcuity Inc.

Healthcare
45K
New
$14.1 - $20.78 $635K - $935K
45K $737K
PLRX
Pliant Therapeutics, Inc.

Healthcare
46.2K
New
$10.58 - $15.61 $489K - $721K
46.2K $496K
Corbus Pharmaceuticals Holdi
64.5K
New
N/A
64.5K $0
Helix Acquisition Corp Ii
178K
New
N/A
178K $0
NAMS
Newamsterdam Pharma CO Nv Shs
22.5K
New
N/A
22.5K $0
Rapport Therapeutics Inc
20K
New
N/A
20K $0
Activity Summary
Buys All Purchases 20 New Holdings 8 Increased Positions 12 Sells All Sells 9 Reductions 9 Sold out 0 Options Calls 0 Puts 1
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email